Post Categories
Sanjay Mitter new VP and Global Head of Clinical Research Services
September 14, 2016
Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics,…
Let’s Talk Neuro at the AAIC 2016 in Toronto, Canada, July 24-27, 2016
July 19, 2016
Join us from July 24-27, 2016 in Toronto, Canada for the Alzheimer’s Association International Conference. QPS neuroscientists will attend the AAIC 2016 and would…
QPS Netherlands scientist Daniel Wilffert nominated for New Investigator Award by Bioanalysis Zone!
June 22, 2016
Since 2012, a New Investigator Award has been given annually to honor excellence among bioanalytical scientists within their first five years in the industry….
We are exhibiting at the DIA 2016 Annual Meeting at our booth #1200 between June 26-30 at Philadelphia, PA, USA.
June 21, 2016
We are exhibiting at the DIA 2016 Annual Meeting at our booth #1200 between June 26-30 at Philadelphia, PA, USA. If you are attending…
Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia!
May 17, 2016
QPS CEO Ben Chien has made it through to the round of 30 (31, actually) being considered for this year’s prestigious EY Entrepreneur Of…
Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability
May 17, 2016
Each year, Life Science Leader honors CROs that are the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. To determine the winners, the…
QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel
May 4, 2016
Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success…
QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug
April 19, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational…
SCIEX and QPS Join Forces to Bring You a New Bioanalysis Solution for Biologics
April 5, 2016
Over the past 10 years, large molecule therapies have increased from 10% to nearly 50% of the typical pharma and biopharmaceutical pipeline. This transition…
QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells
March 25, 2016
QPS and Samsara Sciences have solidified a cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and…
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th
March 9, 2016
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th. Several members of QPS’ Early Phase Clinical team will be…
QPS is proud to announce that our toxicology facility passed a GLP audit by the US FDA in 3Q 2015 with no major findings.
March 7, 2016
We are exhibiting at SOT 55th Annual Meeting and ToxExpoTM. Please visit our booth (#1813) between March 13-16 at the New Orleans Convention Center,…
Discovery: Pupal Ants Produce Milk for Their Colonies
February 1, 2023
Pupating ants produce milk — and scientists have only just noticed. Research published in Nature in November describes researchers observing for the first time…
The Resurgence of Strep A and the Effects of the COVID-19 Pandemic
January 30, 2023
An unexpected increase in cases of streptococcal A (strep A) infection in the United Kingdom is troubling for families, healthcare practitioners, and researchers. Although…
Pigs Could Solve the Organ Transplant Crisis
January 25, 2023
2022 held a number of significant breakthroughs in researchers’ ongoing efforts to solve the organ transplant crisis. Many of those breakthroughs were in xenotransplantation,…
The Unlikely Role of Hops in the Prevention of Alzheimer’s Disease
January 23, 2023
A team of Italian scientists from the University of Milan-Bicocca have recently discovered a possible use of hops, the flowers used to enhance both…
Costly, Life-Changing Type 1 Diabetes Drug Delays Disease, Receives FDA Approval
January 16, 2023
The U.S. Food and Drug Administration has approved teplizumab-mzw (TZIELD™), a drug developed by New Jersey-based Provention Bio to delay the onset of type…
A Breakthrough in Converting Brain Waves to Speech
January 11, 2023
A new pilot study conducted by Chang Lab at UC San Francisco has demonstrated the ability to use new neurotechnology to enable paralyzed individuals…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…